Ferring would like to use cookies to better understand your use of this website and improve your experience while navigating it. Please accept our use of cookies in accordance with our privacy policy. 

Accept / Decline

Our operations

1) Ferring Private Limited (Asia-Pacific Headquarters)

Ferring Pharmaceuticals opened its Asia Pacific headquarters in Singapore on 7 March 2016. Ferring Asia Pacific operations span across diverse geographies encompassing China, Japan, India, Sri Lanka, Bangladesh, Australia, New Zealand, South Africa, South Korea, Taiwan, Hong Kong, Vietnam, Thailand, Malaysia, Singapore, Philippines, Indonesia and Myanmar.

Ferring has been present in the Asia Pacific region for over 28 years and currently employs about 1300 people.

The Headquarters have strategic oversight and executive management responsibilities over the company’s regional entities and activities in Asia Pacific- a region identified for fast growth and future development and investment by the company.

The Headquarters facilitate collaboration across various operational disciplines and see functions such as supply chain planning and coordination, intellectual property management, legal and compliance, IT, business development and planning, marketing, regulatory and medical affairs coming together to support the Asia Pacific countries where Ferring operates.

The company is keen to establish partnerships with hospitals, research institutions and universities to conduct R&D in the company’s prioritized disease areas and those of relevance to the Asia Pacific markets. Ferring is a leader in novel peptide-based drugs and biotechnology derived medicines, such as recombinant proteins and other biologics.

2) Ferring Pharmaceuticals Private Limited (Singapore Marketing and Sales office)

Ferring Marketing & Sales Office was established in Singapore in Oct 2010.  Today, Ferring markets a broad portfolio of pharmaceutical products in therapeutic areas such as Reproductive Health, Urology, Gastroenterology and Endocrinology. At Ferring, we understand that our primary responsibility is the delivery of therapies that bring long-lasting benefits to patients, and in some instances save lives.

Our products:

Reproductive Health
•   Assisted reproduction for infertile patients (ovarian stimulation, implantation support)
•   Pre-term labour
•   Labour induction
•   Post-partum Hemorrhage
•   Primary Noctural Enuresis (Bedwetting in young children)
•   Prostate Cancer
•   Inflammatory Bowel Disease (Crohn’s disease, Ulcerative Colitis)
•   Bleeding Oesophageal Varices
•   Bowel cleansing (before diagnostic intervention or surgery)
•   Central Diabetes Insipidus
•   Growth hormone deficiency in children
•   Turner’s syndrome in girls
•   Central Precocious Puberty in children 

Ferring Private Ltd.
168 Robinson Road
#13-01 Capital Tower  
068912 Singapore

Tel: +65 6812 7500
Fax: +65 6812 7510